Fig. 2From: Immunological outcomes of Tenofovir versus Zidovudine-based regimens among people living with HIV/AIDS: a two years retrospective cohort studyAverage gain in CD4+ count taken every 6 month for a cohort of patients on ART for at least 6 months at JUSH, September, 2012 to July, 2014. Missing values per each regimen at 12, 18 and 24 months respectively: a(2, 7, 11); b(11, 3, 2); c(7, 1, 9); d(5, 12, 4)Back to article page